C07D 275/00
Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
C07D275/00 (Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings) appears on 1,387 US grants and 844 published applications in this corpus.
Search patents in C07D- Granted patents
- 1,387
- Published applications
- 844
- Assignees
- 571
- Inventors
- 3,501
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 22 | 0 |
| 1977 | 44 | 0 |
| 1978 | 36 | 0 |
| 1979 | 42 | 0 |
| 1980 | 36 | 0 |
| 1981 | 40 | 0 |
| 1982 | 13 | 0 |
| 1983 | 17 | 0 |
| 1984 | 13 | 0 |
| 1985 | 14 | 0 |
| 1986 | 21 | 0 |
| 1987 | 21 | 0 |
| 1988 | 22 | 0 |
| 1989 | 25 | 0 |
| 1990 | 28 | 0 |
| 1991 | 26 | 0 |
| 1992 | 30 | 0 |
| 1993 | 30 | 0 |
| 1994 | 27 | 0 |
| 1995 | 33 | 0 |
| 1996 | 63 | 0 |
| 1997 | 45 | 0 |
| 1998 | 39 | 0 |
| 1999 | 49 | 0 |
| 2000 | 27 | 0 |
| 2001 | 32 | 4 |
| 2002 | 27 | 17 |
| 2003 | 19 | 24 |
| 2004 | 17 | 44 |
| 2005 | 12 | 28 |
| 2006 | 18 | 51 |
| 2007 | 24 | 26 |
| 2008 | 26 | 39 |
| 2009 | 20 | 47 |
| 2010 | 32 | 48 |
| 2011 | 31 | 35 |
| 2012 | 30 | 40 |
| 2013 | 31 | 36 |
| 2014 | 36 | 37 |
| 2015 | 37 | 38 |
| 2016 | 25 | 34 |
| 2017 | 35 | 33 |
| 2018 | 26 | 33 |
| 2019 | 28 | 30 |
| 2020 | 21 | 29 |
| 2021 | 16 | 36 |
| 2022 | 22 | 34 |
| 2023 | 11 | 28 |
| 2024 | 20 | 35 |
| 2025 | 14 | 21 |
| 2026 | 14 | 17 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- TEAD inhibitors29 Sep 2026US 12,747,207 B2Orion Corporation
- Phenyl-sulfamoyl-benzoic acid derivatives as ERAP1-modulators28 Jul 2026US 12,692,223 B2Grey Wolf Therapeutics Limited
- Chemical compounds and uses thereof23 Jun 2026US 12,662,451 B2Glaxosmithkline Intellectual Property (No. 4) Ltd.
- Histone deacetylase inhibitors26 May 2026US 12,637,433 B2The University of Queensland
- Metabotropic glutamate receptor negative allosteric modulators (NAMs) and uses thereof26 May 2026US 12,637,436 B2Sanford Burnham Prebys Medical Discovery Institute
- Bleach Catalyst and Composition Comprising Said Catalyst24 Sep 2026US 2026/0286254 A1Reckitt Benckiser Vanish B.V.
- Bleach Catalyst With Improved Performance, Granule Comprising The Bleach Catalyst, And Composition Comprising Said Catalyst Or Said Granule17 Sep 2026US 2026/0275249 A1Reckitt Benckiser Vanish B.V.
- Tetraline, phenylcyclobutane and phenylcyclopentane analogs as rxfp1 agonists10 Sep 2026US 2026/0265208 A1Bristol-Myers Squibb Company
- Crystalline forms and formulations of a kras inhibitor3 Sep 2026US 2026/0258055 A1Eli Lilly and Company
- Globodera pallida control agent20 Aug 2026US 2026/0240154 A1National Agriculture and Food Research Organization
Most cited
By later US patents
- Phenyl heterocycles as cox-2 inhibitors281US 5,474,995 AMerck Frosst Canada, Inc. · 1995
- Phenyl heterocycles as cox-2 inhibitors208US 5,550,142 AMerck Frosst Canada, Inc. · 1996
- Phenyl heterocycles as COX-2 inhibitors204US 5,536,752 AMerck Frosst Canada, Inc. · 1996
- Cyclic amides171US 5,698,579 ACelgene Corporation · 1997
- Prostaglandin synthase inhibitors169US 5,593,994 AThe DuPont Merck Pharmaceutical Company · 1997